Managing Long-Term HIV Survivors

Jan. 30, 2020: Polypharmacy vs. drug interaction risk among people living with HIV as they age; cost-effectiveness of ibalizumab; PrEP persistence on Medicaid vs. private health coverage.

Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.

New scientific evidence suggests that the celebrity-backed diet may have significant cognitive benefits for older people living with HIV.

Comorbidities, mental health issues, loneliness, and financial problems are the biggest issues faced by older people living with HIV, the San Francisco portion of a new report issued by the ACRIA Center on HIV and Aging at GMHC showed.

"Finding the proper balance between risk and benefit can sometimes be more art than science," writes David Fawcett Ph.D., LCSW.

Since 2015, The Reunion Project (TRP) long-term survivors connect and talk about their common experiences. Several workshops at USCA 2018 facilitated by TRP offered long-term survivors a rare opportunity voice to their experiences and feelings.

How food insecurity feeds inflammation; racial disparities in HPV16 prevalence; how HIV meds affect pre-existing neurocognitive impairment; central nervous system inflammation in the setting of HIV treatment success.

The first in a series of interviews with a mentor/mentee pair, David Riedel, M.D., and his mentee, Shruti Gujaran, discuss chronic non-HIV/AIDS-related diseases among older patients with HIV.

Researchers at a Canadian clinic have taken a different approach to their recent analysis of long-term survivors.

Researchers studying quality of life for people with HIV over 50 found that 58% of study participants experienced some degree of loneliness.